About Contact Us Careers

Migraine Nasal Spray Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 4059
Published Date: Dec 24, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Solar Cell Landscape

Upsher-Smith Laboratories, LLC
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Dr. Reddy’s Laboratories Ltd.
AstraZeneca PLC
GlaxoSmithKline plc
Leucadia Pharmaceuticals (Custopharm, Inc.)
Assertio Therapeutics, Inc
Cipla Inc.
Impel Neuro Pharma.Inc
Tonix Pharmaceuticals Holding Corp.
Amneal Pharmaceuticals LLC

Browse Key Market Insights with Data Illustration:

Migraine Nasal Spray Market Size & Share, Growth Report 2037

In the News

March 22, 2022: Impel NeuroPharma, the manufacturer of migraine nasal spray Trudhesa, presented drug performance data at the 2022 scientific meeting of the American Academy of Neurology. The latest data shows rapid and consistent migraine relief with Trudhesa treatment.

Author Credits: Radhika Pawar

Report ID: 4059
Published Date: Dec 24, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of migraine nasal spray is estimated at USD 567.33 million.

Migraine Nasal Spray Market size was valued at USD 536.33 million in 2024 and is likely to cross USD 1.26 billion by 2037, registering more than 6.8% CAGR during the forecast period i.e., between 2025-2037.

North America industry is anticipated to hold largest revenue share by 2037, impelled by increasing cases of migraine, raising awareness, and developing health care infrastructure.

The major players in the market are Upsher-Smith Laboratories, AstraZeneca plc, GlaxoSmithKline plc, Cipla Inc, Dr. Reddyâ€™s Laboratories Ltd, Assertio Therapeutics, Inc., and Impel Neuro Pharma. Inc.

Inquiry Before Buying Request Free Sample